201 related articles for article (PubMed ID: 31978673)
1. Refining cell-based assay to detect MOG-IgG in patients with central nervous system inflammatory diseases.
Kim Y; Hyun JW; Woodhall MR; Oh YM; Lee JE; Jung JY; Kim SY; Lee MY; Kim SH; Kim W; Irani SR; Waters P; Choi K; Kim HJ
Mult Scler Relat Disord; 2020 May; 40():101939. PubMed ID: 31978673
[TBL] [Abstract][Full Text] [Related]
2. Detection of MOG-IgG in Clinical Samples by Live Cell-Based Assays: Performance of Immunofluorescence Microscopy and Flow Cytometry.
Marchionatti A; Hansel G; Avila GU; Sato DK
Front Immunol; 2021; 12():642272. PubMed ID: 34025652
[TBL] [Abstract][Full Text] [Related]
3. International multicenter examination of MOG antibody assays.
Reindl M; Schanda K; Woodhall M; Tea F; Ramanathan S; Sagen J; Fryer JP; Mills J; Teegen B; Mindorf S; Ritter N; Krummrei U; Stöcker W; Eggert J; Flanagan EP; Ramberger M; Hegen H; Rostasy K; Berger T; Leite MI; Palace J; Irani SR; Dale RC; Probst C; Probst M; Brilot F; Pittock SJ; Waters P
Neurol Neuroimmunol Neuroinflamm; 2020 Mar; 7(2):. PubMed ID: 32024795
[TBL] [Abstract][Full Text] [Related]
4. Clinical spectrum and IgG subclass analysis of anti-myelin oligodendrocyte glycoprotein antibody-associated syndromes: a multicenter study.
Mariotto S; Ferrari S; Monaco S; Benedetti MD; Schanda K; Alberti D; Farinazzo A; Capra R; Mancinelli C; De Rossi N; Bombardi R; Zuliani L; Zoccarato M; Tanel R; Bonora A; Turatti M; Calabrese M; Polo A; Pavone A; Grazian L; Sechi G; Sechi E; Urso D; Delogu R; Janes F; Deotto L; Cadaldini M; Bianchi MR; Cantalupo G; Reindl M; Gajofatto A
J Neurol; 2017 Dec; 264(12):2420-2430. PubMed ID: 29063242
[TBL] [Abstract][Full Text] [Related]
5. Deciphering anti-MOG IgG antibodies: Clinical and radiological spectrum, and comparison of antibody detection assays.
Tzartos JS; Karagiorgou K; Tzanetakos D; Breza M; Evangelopoulos ME; Pelidou SH; Bakirtzis C; Nikolaidis I; Koutsis G; Notas K; Chroni E; Markakis I; Grigoriadis NC; Anagnostouli M; Orologas A; Parisis D; Karapanayiotides T; Papadimitriou D; Kostadima V; Elloul J; Xidakis I; Maris T; Zisimopoulou P; Tzartos S; Kilidireas C
J Neurol Sci; 2020 Mar; 410():116673. PubMed ID: 31954354
[TBL] [Abstract][Full Text] [Related]
6. The accuracy of flow cytometric cell-based assay to detect anti-myelin oligodendrocyte glycoprotein (MOG) antibodies determining the optimal method for positivity judgement.
Sugimoto K; Mori M; Liu J; Tanaka S; Kaneko K; Oji S; Takahashi T; Uzawa A; Uchida T; Masuda H; Ohtani R; Nomura K; Hiwasa T; Kuwabara S
J Neuroimmunol; 2019 Nov; 336():577021. PubMed ID: 31473520
[TBL] [Abstract][Full Text] [Related]
7. Frequency and relevance of IgM, and IgA antibodies against MOG in MOG-IgG-associated disease.
Pedreño M; Sepúlveda M; Armangué T; Sabater L; Martínez-Hernandez E; Arrambide G; Blanco Y; Llufriu S; Martínez-Lapiscina EH; Mulero P; Sola-Valls N; Ruiz-García R; Tintoré M; Dalmau J; Graus F; Saiz A
Mult Scler Relat Disord; 2019 Feb; 28():230-234. PubMed ID: 30623863
[TBL] [Abstract][Full Text] [Related]
8. The clinical spectrum and incidence of anti-MOG-associated acquired demyelinating syndromes in children and adults.
de Mol CL; Wong Y; van Pelt ED; Wokke B; Siepman T; Neuteboom RF; Hamann D; Hintzen RQ
Mult Scler; 2020 Jun; 26(7):806-814. PubMed ID: 31094288
[TBL] [Abstract][Full Text] [Related]
9. Aquaporin-4 and Myelin Oligodendrocyte Glycoprotein Autoantibody Status Predict Outcome of Recurrent Optic Neuritis.
Jitprapaikulsan J; Chen JJ; Flanagan EP; Tobin WO; Fryer JP; Weinshenker BG; McKeon A; Lennon VA; Leavitt JA; Tillema JM; Lucchinetti C; Keegan BM; Kantarci O; Khanna C; Jenkins SM; Spears GM; Sagan J; Pittock SJ
Ophthalmology; 2018 Oct; 125(10):1628-1637. PubMed ID: 29716788
[TBL] [Abstract][Full Text] [Related]
10. MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 1: Frequency, syndrome specificity, influence of disease activity, long-term course, association with AQP4-IgG, and origin.
Jarius S; Ruprecht K; Kleiter I; Borisow N; Asgari N; Pitarokoili K; Pache F; Stich O; Beume LA; Hümmert MW; Trebst C; Ringelstein M; Aktas O; Winkelmann A; Buttmann M; Schwarz A; Zimmermann H; Brandt AU; Franciotta D; Capobianco M; Kuchling J; Haas J; Korporal-Kuhnke M; Lillevang ST; Fechner K; Schanda K; Paul F; Wildemann B; Reindl M;
J Neuroinflammation; 2016 Sep; 13(1):279. PubMed ID: 27788675
[TBL] [Abstract][Full Text] [Related]
11. Longitudinal analysis of myelin oligodendrocyte glycoprotein antibodies in CNS inflammatory diseases.
Hyun JW; Woodhall MR; Kim SH; Jeong IH; Kong B; Kim G; Kim Y; Park MS; Irani SR; Waters P; Kim HJ
J Neurol Neurosurg Psychiatry; 2017 Oct; 88(10):811-817. PubMed ID: 28684532
[TBL] [Abstract][Full Text] [Related]
12. Myelin Oligodendrocyte Glycoprotein-Immunoglobulin G in the CSF: Clinical Implication of Testing and Association With Disability.
Kwon YN; Kim B; Kim JS; Mo H; Choi K; Oh SI; Kim JE; Nam TS; Sohn EH; Heo SH; Kim SB; Park KC; Yoon SS; Oh J; Baek SH; Kim BJ; Park KS; Sung JJ; Jung JH; Kim SJ; Park SH; Waters P; Kim SM
Neurol Neuroimmunol Neuroinflamm; 2022 Jan; 9(1):. PubMed ID: 34711644
[TBL] [Abstract][Full Text] [Related]
13. Clinical Usefulness of a Cell-based Assay for Detecting Myelin Oligodendrocyte Glycoprotein Antibodies in Central Nervous System Inflammatory Disorders.
Seok JM; Waters P; Jeon MY; Lee HL; Baek SH; Park JS; Kang SY; Kwon O; Oh J; Kim BJ; Park KA; Oh SY; Kim BJ; Min JH
Ann Lab Med; 2024 Jan; 44(1):56-63. PubMed ID: 37665286
[TBL] [Abstract][Full Text] [Related]
14. Patterns and utility of myelin oligodendrocyte glycoprotein (MOG) antibody testing in cerebrospinal fluid.
Burton JM; Youn S; Al-Ani A; Costello F
J Neurol; 2024 May; 271(5):2662-2671. PubMed ID: 38366070
[TBL] [Abstract][Full Text] [Related]
15. Neuromyelitis optica spectrum disorders with antibodies to myelin oligodendrocyte glycoprotein or aquaporin-4: Clinical and paraclinical characteristics in Algerian patients.
Bouzar M; Daoudi S; Hattab S; Bouzar AA; Deiva K; Wildemann B; Reindl M; Jarius S
J Neurol Sci; 2017 Oct; 381():240-244. PubMed ID: 28991690
[TBL] [Abstract][Full Text] [Related]
16. Myelin Oligodendrocyte Glycoprotein Antibody-Positive Optic Neuritis: Clinical Characteristics, Radiologic Clues, and Outcome.
Chen JJ; Flanagan EP; Jitprapaikulsan J; López-Chiriboga ASS; Fryer JP; Leavitt JA; Weinshenker BG; McKeon A; Tillema JM; Lennon VA; Tobin WO; Keegan BM; Lucchinetti CF; Kantarci OH; McClelland CM; Lee MS; Bennett JL; Pelak VS; Chen Y; VanStavern G; Adesina OO; Eggenberger ER; Acierno MD; Wingerchuk DM; Brazis PW; Sagen J; Pittock SJ
Am J Ophthalmol; 2018 Nov; 195():8-15. PubMed ID: 30055153
[TBL] [Abstract][Full Text] [Related]
17. Retrospective analysis of children with myelin oligodendrocyte glycoprotein antibody-related disorders.
Konuskan B; Yildirim M; Gocmen R; Okur TD; Polat I; Kilic H; Saltik S; Ozturk Z; Gucuyener K; Altunbasak S; Celik T; Kose G; Yilmaz A; Komur M; Kayilioglu H; Anlar B
Mult Scler Relat Disord; 2018 Nov; 26():1-7. PubMed ID: 30212767
[TBL] [Abstract][Full Text] [Related]
18. Relevance of antibodies to myelin oligodendrocyte glycoprotein in CSF of seronegative cases.
Mariotto S; Gajofatto A; Batzu L; Delogu R; Sechi G; Leoni S; Pirastru MI; Bonetti B; Zanoni M; Alberti D; Schanda K; Monaco S; Reindl M; Ferrari S
Neurology; 2019 Nov; 93(20):e1867-e1872. PubMed ID: 31645473
[TBL] [Abstract][Full Text] [Related]
19. MOG-IgG in primary and secondary chronic progressive multiple sclerosis: a multicenter study of 200 patients and review of the literature.
Jarius S; Ruprecht K; Stellmann JP; Huss A; Ayzenberg I; Willing A; Trebst C; Pawlitzki M; Abdelhak A; Grüter T; Leypoldt F; Haas J; Kleiter I; Tumani H; Fechner K; Reindl M; Paul F; Wildemann B
J Neuroinflammation; 2018 Mar; 15(1):88. PubMed ID: 29554927
[TBL] [Abstract][Full Text] [Related]
20. Persistent MOG-IgG positivity is a predictor of recurrence in MOG-IgG-associated optic neuritis, encephalitis and myelitis.
Oliveira LM; Apóstolos-Pereira SL; Pitombeira MS; Bruel Torretta PH; Callegaro D; Sato DK
Mult Scler; 2019 Dec; 25(14):1907-1914. PubMed ID: 30417715
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
